Allergy & Immunology CE Activities

Updates in Hereditary Angioedema Care from the HAEA

1.0 CE Credit(s)

Reinforcing the Roles of Biologic Therapy and Interprofessional Care in Improving Patient Outcomes (1 of 3)

0.25 CE Credit(s)

Optimizing Biologic Therapy in Children with Moderate-to-Severe Atopic Dermatitis: A Care Team Forum®

1.0 CE Credit(s)

Challenging Cases in Asthma: Improving Quality of Life (3 of 3)

0.25 CE Credit(s)

Challenging Cases in Asthma: Optimizing Biologics in Adults (2 of 3)

0.25 CE Credit(s)

Assessing the Potential Implications of New Data in Chronic Spontaneous Urticaria

0.25 CE Credit(s)

ALLERGY & iMMUNOLOGY blog

6 Ways to Personalize Your Patient’s Asthma Treatment Plan

Asthma management is increasingly becoming more personalized. Here are 6 ways you can help personalize treatment for your patients with asthma that is severe or difficult to control.

Allergy & Immunology, Pulmonology
Blog

Try These Diets for Your Patients with EoE

In infancy, you can see feeding problems, and as the child progresses to adulthood, you will see them complain about vomiting, abdominal pain, difficulty swallowing, food impaction, and all of this may cause them to avoid eating certain foods, eat very slowly, or avoid social situations where food is involved.

Allergy & Immunology
Blog

RMEI Presentations

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we’ve learned so far

LATEST ALLERGY & IMMUNOLOGY ARTICLES

Latest Allergy & Immunology Articles

CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma April 11, 2024
WHIM-like syndrome (warts, hypogammaglobulinemia, infections, and myelokathexis) developed in a patient with gain of CXCR4 function. Plerixafor, a CXCR4 antagonist, led to symptom reduction.
Viviana Marin-Esteban, Lucie Molet, Marta Laganà, Dragos Ciocan, Clément Dominguez-Lafage, Nagham Alouche, Julie Nguyen, Carmen Gallego, Françoise Mercier-Nomé, Agnieszka Jaracz-Ros, Blandine Beaupain, Jérôme Bouligand, Alexis Proust, Christophe Habib, Rémy A. Bonnin, Delphine Girlich, Fanny Fouyssac, Jean-Luc Schmutz, Anne-Claire Bursztejn, Christine Bellanné-Chantelot, Emmanuelle Bourrat, Michael Herfs, Marion Espéli, Karl Balabanian, Géraldine Schlecht-Louf, Jean Donadieu, Françoise Bachelerie, Claire Deback
Case 11-2024: An 82-Year-Old Woman with Falls and Cognitive Decline April 11, 2024
An 82-year-old woman was admitted because of difficulty walking, falls, and cognitive decline. Light touch of the right hand, right knee, and both feet caused pain. A diagnosis was made.
Sharon A. Chung, Ambrose J. Huang, Mandakolathur R. Murali, Bart K. Chwalisz, Zachary S. Wallace, Liana N. Kozanno
Science behind the Study: CAR T-Cell Therapy for Glioblastoma April 11, 2024
Glioblastoma is the most formidable of primary brain tumors, owing to its aggressive nature and the limited efficacy of the best available treatment, which comprises maximal safe surgical resection, radiotherapy, and alkylating chemotherapy. Most patients die within a year after diagnosis, which underscores the urgent need for innovative therapeutic strategies....
Misty R. Jenkins, Katharine J. Drummond

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Gastroenterology
2021

Allergy & Immunology CE Activities

ALLERGY & iMMUNOLOGY blog

6 Ways to Personalize Your Patient’s Asthma Treatment Plan

Try These Diets for Your Patients with EoE

RMEI Presentations

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we’ve learned so far

LATEST ALLERGY & IMMUNOLOGY ARTICLES

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

Previously Published CE Activities